Typhoid Fever: Ceftriaxone Dosing and Step-Down to Oral Cefixime
For typhoid fever, use ceftriaxone 80 mg/kg IV once daily (maximum 2 g/day) for 5–7 days, and you can step down to oral cefixime 10–20 mg/kg/day (maximum 400 mg/day) after clinical improvement—typically after defervescence—to complete a total treatment course of 7–14 days.
Ceftriaxone Dosing and Duration
The WHO Pocket Book recommends ceftriaxone 80 mg/kg IV once daily for 5–7 days as second-line therapy for typhoid fever 1. This is the guideline-endorsed regimen for children and applies to resource-limited settings where ciprofloxacin resistance is common.
- Pediatric dose: 80 mg/kg IV once daily (maximum 2 g/day)
- Adult dose: 2 g IV once daily
- Duration: 5–7 days is the standard recommendation 1
Research evidence supports flexibility in duration:
- A 5-day course of ceftriaxone (75 mg/kg/day) achieved clinical cure in 79% of patients, with faster blood culture clearance than chloramphenicol 2
- A 3-day course (3–4 g daily in adults) cured 95–100% of patients, though some experienced prolonged fever 3
- A flexible-duration approach (continuing until defervescence plus 5 additional days) achieved 100% clinical cure with no relapses 4
Clinical pearl: While 3-day courses have been studied, the 5–7 day duration is safer and more widely endorsed to prevent treatment failure and relapse, especially in areas with emerging resistance.
Step-Down to Oral Cefixime
You can step down to oral cefixime once the patient is clinically improving and afebrile, rather than completing the full 7 days of IV therapy. This is supported by both research evidence and the FDA-approved indication for cefixime in typhoid fever.
Cefixime Dosing (FDA-Approved)
- Pediatric dose: 8 mg/kg/day orally, given as a single daily dose or divided every 12 hours (maximum 400 mg/day) 5
- Adult dose: 400 mg orally once daily 5
- Duration: Complete a total treatment course of 7–14 days (combining IV and oral therapy)
Evidence for Step-Down Strategy
Research directly comparing cefixime to ceftriaxone for typhoid fever demonstrates:
- Oral cefixime (10 mg/kg/day divided every 12 hours for 14 days) was as effective as IV ceftriaxone (65 mg/kg/day for 14 days) in children with multidrug-resistant typhoid 6
- Time to defervescence was comparable (8.0 vs 8.3 days)
- Relapse rates were similar (1 in cefixime group vs 3 in ceftriaxone group)
- No adverse effects were observed with oral cefixime 6
Practical approach: Start with ceftriaxone 80 mg/kg IV daily. Once the patient is afebrile for 24–48 hours and clinically improving (typically by day 3–5), switch to oral cefixime 8–10 mg/kg/day to complete 7–10 days total therapy. This mirrors the osteomyelitis approach in the WHO guidelines, where IV therapy is given for initial control followed by oral step-down 1.
Important Caveats
Resistance patterns matter: Cefixime may not perform as well as fluoroquinolones in areas where organisms remain fluoroquinolone-susceptible 7. However, in South Asia where fluoroquinolone resistance is common, cephalosporins are preferred 7, 8.
Cefixime penetrates cells: Unlike other β-lactams, cefixime achieves 46–48% intracellular concentration and can inhibit intracellular Salmonella growth 9, explaining its clinical effectiveness despite being oral.
Monitor for treatment failure: If fever persists beyond 7–10 days or the patient deteriorates, consider treatment failure and switch to an alternative agent (azithromycin 20 mg/kg/day for 5–7 days per WHO guidelines 1).
Avoid premature step-down: Ensure the patient is truly improving before switching to oral therapy. Persistent high fever, severe toxicity, or complications warrant continued IV therapy.
Total duration: The combined IV + oral course should be at least 7 days, with 10–14 days preferred in severe cases or when clinical response is delayed 1, 4, 7.